共 209 条
[31]
Arlin ZA(2011)Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment J Clin Oncol 29 4417-582
[32]
Periman PO(2013)Pyrosequencing of clinically relevant polymorphisms Methods Mol Biol 1015 97-1029
[33]
Todd MB(2009)Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers Drug Metab Dispos 37 1759-113
[34]
Pastore F(2012)Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues Xenobiotica 42 266-116
[35]
Dufour A(1999)Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism Clin Pharmacol Ther 65 576-2074
[36]
Benthaus T(2007)Influence of mutations associated with Gilbert and Crigler–Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates Pharmacogenet Genomics 17 1017-undefined
[37]
Metzeler KH(2003)Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D Drug Metab Dispos 31 108-undefined
[38]
Maharry KS(2014)Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: a quantitative systematic review Pharmacol Ther 141 92-undefined
[39]
Schneider S(2013)Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia N Engl J Med 368 2059-undefined
[40]
Santamaria CM(undefined)undefined undefined undefined undefined-undefined